Atlas Trials

A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With Hypoalbuminemia

Clinical trial NCT06355479 · COMPLETED

Trial details

NCT number
NCT06355479
Sponsor
Healthgen Biotechnology Corp.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HypoalbuminemiaHepatic Cirrhosis
Start date
2023-04-10
Primary completion
2023-11-22
Enrollment
328

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.